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in Pediatric Patients, With Observations on
Surgical Therapy for Ventricular Tachycardia
Christina Y. Miyake, MD, Pedro J. Del Nido, MD, Mark E. Alexander, MD, Frank Cecchin, MD,
Charles I. Berul, MD, John K. Triedman, MD, Tal Geva, MD, Edward P. Walsh, MD
Boston, Massachusetts
Objectives The aim of this study was to describe a large experience with primary cardiac tumors in pediatric patients, char-
acterize associated arrhythmias, and expand knowledge of natural history and treatment options.
Background Primary cardiac tumors in children are rare. The incidence of arrhythmias is not well-defined, and management
plans vary widely.
Methods We employed a retrospective single-center review of patients 21 years of age diagnosed with a primary car-
diac tumor between 1968 and 2010. Clinically significant arrhythmias were defined as: 1) sudden cardiac arrest;
2) nonsustained and sustained ventricular tachycardia (VT); 3) pre-excitation; and 4) sustained supraventricular
tachycardia of any mechanism.
Results A total of 173 patients were identified: 106 rhabdomyoma, 25 fibroma, 14 myxoma, 6 vascular, 4 teratoma,
3 lipoma, and 15 other. Median age at diagnosis was 7 months (prenatal to 21 years). Of these, 42 (24%) had
clinically significant arrhythmias. Patients with large fibromas were the highest-risk group, with VT occurring in
64%. Among rhabdomyoma patients, 10% had pre-excitation, and 6% had VT. Over a mean follow-up of 6 years
(1 day to 34 years, median 4 years), surgical excision was performed in 62 cases, with rhythm treatment being
1 of the indications in 20. Post-operatively, clinically significant arrhythmias were eliminated in 18 of these 20,
including all 13 fibroma patients.
Conclusions Clinically significant arrhythmias occurred in 24% of pediatric patients with cardiac tumors, VT being the most
common type. Surgical excision for VT associated with rhabdomyomas and fibromas in selected patients is an
important and effective management strategy in these patients. (J Am Coll Cardiol 2011;58:1903–9) © 2011
by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.08.005Primary cardiac tumors in children are rare, with an inci-
dence ranging between 0.03% and 0.32% (1–4). Although
most are pathologically benign, they can be associated with
serious cardiovascular complications, including intracavitary
obstruction, coronary artery compromise, thromboembolic
events, and rhythm disturbances (5–16). Data regarding
associated arrhythmias and their treatment have been largely
limited to case reports or small series (6,8,9,11–30). The
most substantial study to date came from Beghetti et al.
(20), who identified 56 pediatric patients with various tumor
types and described arrhythmias in 11 cases. The purpose of
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Dr. Walsh has received a speaker honorarium from St. Jude Medical. All other
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paper to disclose.Manuscript received May 9, 2011; revised manuscript received July 15, 2011,
accepted August 9, 2011.this study was to describe a relatively large experience with
arrhythmias in pediatric patients with cardiac tumors and
expand understanding of the natural history and treatment
options.
Methods
This was a retrospective review describing all patients 21
years of age seen at Children’s Hospital Boston between
October 1968 and October 2010 with a primary cardiac tumor.
Medical records were reviewed with permission of the hospital
Committee on Clinical Investigation. Patients with secondary
tumors due to metastatic disease were excluded. Patients with
large non-neoplastic cysts involving the heart or pericardial
space were included for review because of the known associa-
tion of such masses with rhythm disturbances (31). The
diagnosis of cardiac tumor was made by echocardiogram
and/or magnetic resonance imaging in the current era or by
angiography in years before noninvasive imaging capabilities.
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Arrhythmias in Pediatric Cardiac Tumors October 25, 2011:1903–9Records were examined for all in-
formation pertaining to rhythm
status, including narrative history,
electrocardiograms (ECG), Holter
monitors, electrophysiological stud-
ies, and operative notes. Follow-up
data were obtained from hospital
records or, in some cases, by con-
tact with the referring cardiologist.
Emphasis was placed on rhythm
disorders that were judged to be
“clinically significant,” defined a
priori as: 1) sudden cardiac arrest
with documented or suspected
ventricular fibrillation (VF); 2)
ventricular tachycardia (VT), ei-
ther sustained (30-s duration)
or nonsustained (3 beats, 30-s duration); 3) presence of
manifest pre-excitation on ECG (Wolff-Parkinson-White
syndrome [WPW]) whether or not there was a history of
supraventricular tachycardia (SVT); and 4) SVT involving
mechanisms other than WPW (e.g., ectopic atrial tachycar-
dia [EAT], atrial flutter, or orthodromic re-entry via a
“concealed” accessory pathway), but only if sustained. Note
was also made of certain “low-grade” arrhythmias (e.g.,
frequent ventricular ectopic beats or couplets, brief nonsus-
tained SVT), although these were considered clinically
inconsequential for purposes of this study.
Results
Overview. Over a span of 42 years, 173 patients were seen
with a primary cardiac tumor at Children’s Hospital Boston.
Patient and tumor characteristics by tumor type are sum-
marized in Table 1. Detection of cardiac tumors became
much more frequent after introduction of high-quality
echocardiography and magnetic resonance imaging, with
nearly 80% of the cases being diagnosed during the most
recent 2 decades of the review period.
Over a mean follow-up of 6 years (1 day to 34 years,
median 4 years), 42 of the 173 study patients (24%) had at
least 1 clinically significant rhythm disorder, as detailed in
Table 2. There were 4 sudden cardiac arrests (2%). Three of
these patients (2 with fibromas, and 1 with a Purkinje cell
tumor) were successfully resuscitated and subsequently
found to have malignant VT that required aggressive
therapy. The fourth arrest patient, who had a vascular tumor
(hemangioma) and an antecedent history of only isolated
ventricular premature beats, expired with the event and was
presumed to have suffered VF after no alternate cause was
uncovered at autopsy.
A total of 27 patients (16%) had documented VT. This
was the most common arrhythmia in the study group and
was most prevalent among those with fibromas. Pre-
excitation was present on ECG in 6% of the study group,
Abbreviations
and Acronyms
AV  atrioventricular
EAT  ectopic atrial
tachycardia
ECG  electrocardiogram
LV  left ventricle/
ventricular
SVT  supraventricular
tachycardia
VF  ventricular fibrillation
VT  ventricular
tachycardia
WPW  Wolff-Parkinson-
White syndromealthough not all these patients experienced sustained SVT Pa T n F M H S A D M T Va
lu
su
pr
m
yo m
ardia (S
ome.
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in patients with rhabdomyomas. Sustained SVT involving
mechanisms other than WPW was observed in 5% of the
study group. Some patients had more than 1 clinically
significant arrhythmia. Lower-grade arrhythmias that were
considered of minimal clinical concern (although still ab-
normal for age) were observed in another 9% of the study
group. Apart from 1 patient with surgically induced heart
block after tumor resection, no other instance of bradycardia
or atrioventricular (AV) block was observed. Roughly two-
thirds of patients had no arrhythmia of any sort detected
during follow-up.
There were a total of 10 patient deaths during follow-up,
6 of which could be directly attributed to the cardiac tumor
or its treatment (Table 1). Complications due to attempted
tumor excision in small infants accounted for 3 of the 6
deaths. The other 3 tumor-related deaths included 1 case of
metastatic brain involvement in a patient with a vascular
tumor (hemangioendothelioma), 1 case of low cardiac
output in an infant with large obstructive rhabdomyomas
not felt to be a candidate for surgery, and the 1 late sudden
death in the aforementioned patient with a hemangioma.
Arrhythmias according to tumor type. RHABDOMYOMA.
Rhabdomyomas were the most common tumors encoun-
tered in this study (106 of 173 cases, 61%). Most of these
patients (78 of 106, 74%) carried a diagnosis of tuberous
sclerosis. A majority of patients (42%) were diagnosed
during a prenatal ultrasound or during evaluation for sus-
pected tuberous sclerosis. Other presentations included
murmur (16%), arrhythmia (13%), abnormal chest x-ray
(11%), congestive heart failure (11%), incidental (11%),
thromboembolism (2%), and other (8%). Reduction in both
the size and number of tumors was common with increasing
age (4), so that hemodynamic symptoms and arrhythmic
events typically occurred early in life and often resolved over
time.
Clinically significant arrhythmias were present at some
point in 17 patients (16%). Six presented with VT, usually
in infancy or early childhood. Two patients were treated
effectively with antiarrhythmic medications (propranolol,
Arrhythmias by Tumor TypeTable 2 Arrhythmias by Tumor Type
All Tumors Rhabdomyo
Patients, n 173 106
Clinically significant arrhythmia 42 (24%) 17 (16%
Cardiac arrest/VF 4 (2%) —
VT 27 (16%) 6 (6%)
WPW/sustained SVT 2 (1%) 2 (2%)
WPW/no SVT 9 (5%) 8 (8%)
Non-WPW sustained SVT 9 (5%) 5 (5%)
Low-grade arrhythmia 15 (9%) 13 (12%
Any arrhythmia (low-grade  clinically significant) 57 (33%) 30 (28%
Values are n or n (%). Some patients might have hadmore than 1 arrhythmia. Clinically significant a
atrial beats, ventricular ectopic beats or couplets, and brief nonsustained supraventricular tachyc
VF  ventricular fibrillation; VT  ventricular tachycardia; WPW  Wolff-Parkinson-White syndrsotalol) and ultimately had resolution of VT as tumor sizeregressed. Three patients with VT underwent surgical
excision of a large tumor at ages 3 weeks, 1 month, and 6
years. All 3 had successful elimination of VT. The final
patient did not present with VT until age 17 years. She had
undergone open surgical biopsy of a large left ventricular
(LV) tumor early in life. Years later she developed recurrent
episodes of rapid VT despite tumor regression, and antiar-
rhythmic drug trials failed. When mapped at electrophysi-
ological study, VT seemed to relate to scarring at the old
epicardial biopsy site but could not be ablated with either an
endocardial or epicardial catheter approach (pericardial
adhesions precluded epicardial access to target site). The
patient ultimately underwent placement of an implantable
cardioverter defibrillator, which discharged appropriately on
several occasions for rapid VT. In this case, VT might have
been caused by the biopsy scar rather than the tumor itself.
Ten patients had manifest pre-excitation, 2 with recur-
rent sustained SVT, and 8 who were asymptomatic. The 2
symptomatic WPW patients (2-week-old with a single
right-sided accessory pathway, 5-year-old with multiple
pathways) underwent successful radiofrequency catheter
ablation procedures. The site(s) of successful ablation cor-
responded grossly to regions of tumor on echocardiogram.
Of the patients with asymptomatic pre-excitation, 6 had
spontaneous resolution of their delta waves with increasing
age, although 2 still had pre-excitation persisting into
teenage years. Sustained SVT caused by non-WPW mech-
anisms was present in 5 patients (2 “concealed” accessory
pathways, 3 EAT). The EAT was initially suppressed with
medications and later resolved completely as tumor re-
gressed. Age at which resolution of a delta wave or EAT
occurred varied widely between 1 and 12 years.
FIBROMA. A total of 25 patients were diagnosed with a
cardiac fibroma. The most common presenting symptoms
included arrhythmia (32%), murmur (20%), and abnor-
mal chest x-ray (20%). Clinically significant arrhythmias
were more common in fibroma patients than any other
tumor group. Sixteen patients (64%) had documented
VT, 2 of whom presented with VF arrest (age 3 weeks
Fibroma Myxoma Vascular Teratoma Lipoma Other
25 14 6 4 3 15
16 (64%) 1 (7%) 1 (17%) 0 0 7 (47%)
2 (10%) — 1 (17%) — — 1 (6%)
16 (64%) 1 (7%) — — — 4 (27%)
— — — — — —
— — — — — 1 (7%)
— — — — — 5 (33%)
1 (4%) 1 (7%) — — — —
17 (68%) 2 (14%) 1 (17%) 0 0 7 (47%)
ias are subdivided by type and defined in text. Low-grade arrhythmias included frequent premature
VT) in patients without manifest pre-excitation.ma
)
)
)
rrhythmand 2 months). Baseline ECG in the majority of fibroma
a
a
T
a
v
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Arrhythmias in Pediatric Cardiac Tumors October 25, 2011:1903–9patients demonstrated T-wave abnormalities, and VT
morphologies on ECG were consistent with an origin
near the tumor site (Fig. 1). Sustained VT with hemo-
dynamic instability requiring urgent intervention was
present in 8 of these 16 patients, whereas the other
one-half presented in more stable condition with inter-
mittent episodes of nonsustained VT.
Direct current cardioversion interrupted sustained VT in
the 2 cases when it was attempted. Experience was too
limited and varied to judge specific efficacy of drug therapy.
Anecdotally, lidocaine did not seem to interrupt or suppress
VT, although success was observed in some cases when it
was used in combination with procainamide. Amiodarone
suppressed nonsustained VT in some instances but only
provided rate slowing when VT was sustained.
The mechanism for VT in these cases seemed consistent
with re-entry, because episodes were usually monomorphic
and regular in rate, and electrical cardioversion succeeded
when tried. In selected patients undergoing preoperative
electrophysiology studies, VT was inducible and terminable
with pacing maneuvers. However, the rate and morphology
of induced VT often differed from the clinical tachycardia.
Furthermore, some patients demonstrated multiple VT
morphologies over time, and some had polymorphic VT.
Figure 1 Patient With a Left Ventricular Fibroma
(A) Common electrocardiographic changes in this patient and a majority of patient
(B) electrocardiogram of this patient in ventricular tachycardia, and (C) pre- and p
a large left lateral ventricular fibroma.Although these observations could be explained by varied
exit points from a re-entrant circuit, triggered automaticity
cannot be dismissed.
Thirteen of the 16 VT patients underwent attempted
fibroma excision. There were no surgical deaths, and VT
was eliminated in all cases. Of the 3 VT patients who did
not undergo resection (2 diagnosed in 1970s and felt to
be inoperable, 1 parent choice), 2 continue to have
nonsustained VT while receiving antiarrhythmic medica-
tion but are asymptomatic, and the third improved over a
35-year period to a pattern of low-grade ectopy off
medications. The size of the fibroma in relation to cardiac
mass decreased with somatic growth in unoperated pa-
tients, but unlike rhabdomyomas, fibromas never resolved
completely over time.
MYXOMA. A total of 14 patients were diagnosed with
myxoma, 3 of whom had associated Carney Syndrome.
Patients were diagnosed due to murmur (n  3), thrombo-
embolism (n 3), family history of Carney Syndrome (n 2),
rrhythmia (n  1), congestive heart failure (n  1),
bnormal ECG (n  1), and incidental finding (n  2).
umor locations included 6 left atrium, 2 right atrium, 1
trial septum, 2 right ventricle, 1 LV, and 2 from the aortic
alve. Only 1 patient had a clinically significant arrhythmia
left ventricular fibromas demonstrating T-wave inversions in left lateral leads,
erative echocardiographic images of the same patient after surgical resection ofs with
ost-op
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1
p
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resection of a tumor from the left atrium.
VASCULAR TUMOR. Six patients were diagnosed with vas-
cular tumors, including 5 with hemangiomas, and 1 with
malignant hemangioendothelioma that developed into met-
astatic disease. Patients were diagnosed due to a variety of
reasons, including arrhythmia, prenatal ultrasound, syncope,
and chest pain. The only clinically significant rhythm event
in this group involved the hemangioma patient who expired
with sudden cardiac arrest.
TERATOMA. Four patients were diagnosed with teratomas
1 left atrial, 3 pericardial). Two patients were diagnosed
ue to abnormal chest x-rays, 1 by prenatal ultrasound, and
due to syncope. Tumors resulted in hemodynamic com-
romise in all 4 patients, but none had associated arrhyth-
ias. One patient developed surgically induced heart block
equiring a pacemaker after tumor resection.
LIPOMA. Three patients were diagnosed with primary car-
diac lipomas—1 due to a murmur, and 2 incidentally.
Tumors were located in the right AV groove, right ventric-
ular apex, and central fibrous body. None of the patients had
arrhythmias, hemodynamic compromise, or coronary
involvement.
OTHER. A group of 15 patients had a variety of rare tumor
ypes, as catalogued in the legend for Table 1. Clinically
significant arrhythmias were present in 7 (47%). Arrhythmia
was the most common presenting symptom. The most
dramatic case involved an infant who was resuscitated from
cardiac arrest and found to have intractable VT due to
diffuse Purkinje cell tumor involving the apex and LV
septum. Incidental pre-excitation but no SVT was also seen
in this case. Despite surgical debulking of the apical portion
of the tumor at age 13 months, VT promptly recurred.
Three catheter ablation sessions with radiofrequency lesions
along the LV septum were required in the weeks after
surgery until VT could finally be controlled with medica-
tions. Residual ventricular arrhythmia then gradually de-
creased over several years. He is presently doing well on
beta-blocker therapy alone more than 10 years later. Three
other patients (1 with a foregut cyst, 2 with unclassified fatty
tumors) had nonsustained VT that was managed medically.
Sustained SVT in the form of EAT was present in 3
patients with cystic masses (2 right atrial blood cysts, 1
foregut cyst within the triangle of Koch). Despite drainage
of the blood cysts (1 surgically, 1 by transcatheter puncture),
EAT persisted. Resection of the foregut cyst was deemed
inadvisable because of its location near the AV node. All 3
patients had persistent EAT over many years of follow-up,
with only partial control on medical therapy. In fact, the
patient with the surgically drained blood cyst developed
tachycardia-induced myopathy from nearly incessant EAT
19 years after the operation. Diffusely abnormal right atrial
tissue with multiple arrhythmia foci was mapped during an
unsuccessful catheter ablation attempt. The EAT was ulti-mately controlled with a combination of medications, and
ventricular function normalized. The final patient with SVT
had both a “concealed” accessory pathway and atrial flutter
in the setting of an inflammatory pseudotumor occupying
50% of the right atrium. After surgical excision, the patient
has had no subsequent arrhythmias and is taking no
antiarrhythmic medications.
Surgical outcomes. A total of 69 patients were referred to
surgery; 5 for biopsy alone, and 64 (37%) for intended
tumor resection. Resection attempts were abandoned in 2
cases when the tumor was found to involve critical structures
upon direct inspection. Total or subtotal resection was
attempted in the remaining 62 patients.
Indications for surgery varied according to tumor type. A
subgroup of 21 patients were referred for rhythm indica-
tions, including 3 with rhabdomyoma (3 VT), 13 with
fibroma (13 VT), 1 with myxoma (VT), and 4 with other
rare tumors (1 Purkinje cell tumor with VT, 1 blood cyst
with SVT, 1 inflammatory pseudotumor with SVT, 1
foregut cyst with SVT). In the patient with the foregut cyst,
the tumor was found to be unresectable, due to its location
within the triangle of Koch. Clinically significant arrhyth-
mias were eliminated in 18 of the remaining 20 patients
(Fig. 2). For the 18 VT patients, 17 cases had resolution of
ventricular arrhythmias, with the only failure being the
patient with diffuse Purkinje cell tumor (Fig. 2). Five
continued receiving empiric treatment with beta-blocker,
whereas the others received no antiarrhythmic medications.
Seven recent patients underwent post-operative electro-
physiology studies with negative ventricular stimulation. Of
the 3 SVT cases, 1 was deemed unresectable, and 1 had a
successful outcome after removal of an atrial pseudotumor,
but EAT persisted in the patient with a right atrial blood
cyst. The tumor itself served as a suitable surgical target in
most cases, so that intraoperative arrhythmia mapping was
only employed on 4 occasions. Surgical technique involved
complete resection when possible, although subtotal resec-
tion was performed in 8 cases when critical structures were
deemed at risk. Surgical cryoablation lines extending beyond
the tumor region to interrupt specific arrhythmia foci or
conduction corridors were only added in 3 cases.
A single patient with a fibroma in the arrhythmia group
required reoperation due to residual subaortic obstruction.
There were no surgical or late deaths. Long-term compli-
cations included the appearance of a ventricular wall aneu-
rysm at the site of tumor resection in 3 infants. Two are
otherwise doing well with normal global ventricular func-
tion, but 1 patient required surgical reoperation to reduce
the aneurysm size and is left with a moderate degree of
global ventricular dysfunction. Two other infants, both with
concomitant congenital heart disease (1 with an atypical
cleft mitral valve and mitral regurgitation, 1 with a subaortic
membrane) have mild-to-moderate global dysfunction
without aneurysms after surgical excision of large LV
fibromas.
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indications in 44 patients. One was found to have a
nonresectable tumor (1 plexiform neurofibroma wrapping
around the mitral valve apparatus). Tumor recurrence was
noted after resection in 1 myxoma patient with Carney
Syndrome. There were 3 surgical deaths in the non-
arrhythmia subgroup—2 infants with large rhabdomyomas
(coronary artery injury and mitral valve injury), and 1 infant
with a teratoma (coronary artery injury). Other complica-
tions included phrenic nerve injury in 1 patient, 1 case of
surgically induced heart block requiring a pacemaker, and 1
post-operative stroke. One patient in the non-arrhythmia
surgical group exhibited mild-to-moderate global dysfunc-
tion but no aneurysm. Patients who developed post-
operative aneurysms and/or ventricular dysfunction in this
series were all infants notable for having the largest tumor
volumes when corrected for body surface area.
Discussion
Optimal management strategy for pediatric patients with
cardiac tumors remains unclear, particularly when serious
arrhythmias are present. This large descriptive series of 173
patients expands the data available on this topic and
provides new observations on the role of surgical interven-
tion. Approximately one-half of the patients had 1 or more
tumor-related symptoms due to hemodynamic obstruction,
thromboembolic events, or rhythm disturbances, and sur-
gery ultimately had to be performed in two-thirds of these
symptomatic cases (46 cases).
Clinically significant arrhythmias were documented in
24% of the study group. The highest arrhythmia burden was
Figure 2 Surgical Patients: Flow Chart of All Patients Who Und
A breakdown by tumor type and the number of patients who had successful elimin
complications including death, aneurysm, and myocardial dysfunction are listed by
CHB  complete heart block; LV  left ventricular; SVT  supraventricular tachycaseen in the fibroma group, who were strongly predisposed toVT that was often life-threatening and difficult to control.
Multiple prior reports of sudden cardiac arrest in these
patients (6,9,12–14,18) attest to the gravity of this condi-
tion. Clinical observations from this study support re-entry
as the most likely VT mechanism, although triggered
automaticity cannot be excluded. Management can include
antiarrhythmic medications, placement of an implantable
cardioverter defibrillator, surgical excision, and even heart
transplantation. Our experience indicates that tumor resec-
tion can be a very effective option, a view supported by
multiple prior reports of successful VT surgery in this
setting (6,21,22,29,30). The VT was eliminated without
recurrence in all 13 of our fibroma patients undergoing
operation. It was notable that success was achieved with
both total and subtotal resection, suggesting that significant
debulking of the tumor mass might be sufficient to reverse
the arrhythmogenic substrate.
Rhabdomyoma patients presented a more diverse as-
sortment of arrhythmias, but pre-excitation stood out as
relatively common in this group, at least at younger ages
before these tumors begin to regress. The majority of the
rhabdomyoma patients with WPW were asymptomatic.
When necessary, catheter ablation can successfully elimi-
nate the accessory pathway, as it did in 2 of our highly
symptomatic cases, but pre-excitation quite often will
resolve spontaneously over time. Improvement in rhythm
status with tumor regression was also seen in rhabdomy-
oma patients with VT and non-WPW forms of SVT. It
seems reasonable to recommend that, whenever possible,
medical therapy be used as a temporizing measure in
rhabdomyoma patients, allowing tumors to regress before
nt Attempted Surgical Excision
of arrhythmias among the 62 patients who underwent resection. Post-operative
r type. *See text for details of complications and arrhythmia surgery outcomes.
VT  ventricular tachycardia.erwe
ation
tumo
rdia;resorting to invasive options. However, in acutely unsta-
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effective roles.
Surgery for resection of a large tumor mass is not without
risks. There were 3 surgical deaths (5%), although these
cases all involved ill infants with large tumors for whom
transplant might have been the only alternative. There were
no deaths among the 21 patients undergoing surgery for
arrhythmia indications. The appearance of post-operative
ventricular wall aneurysms and global systolic dysfunction in
infants is an issue that will deserve long-term attention. All
infants who undergo tumor resection should be followed
carefully with serial echocardiograms to screen for these
potential complications.
Conclusions
Cardiac tumors in children can be associated with serious
arrhythmias in approximately one-quarter of cases. Patients
with large fibromas seem to be the most concerning group,
with a VT risk exceeding 50%. Surgical excision of such
tumors can be a highly effective management option.
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